A Prescription Drug User Fee Act target date of January 28, 2026 has been set for the application. The Food and Drug Administration (FDA) has accepted the New Drug Application (NDA) for Brimochol ™ ...

If you’re over age 40 and you notice that words are starting to seem blurrier when you read, you’re not going crazy. There’s a good chance you’re experiencing presbyopia. Presbyopia is an age-related, ...

Please provide your email address to receive an email when new articles are posted on . The submission is supported by positive data from the phase 3 BRIO-I and BRIO-II studies. If approved, Brimochol ...

Please provide your email address to receive an email when new articles are posted on . Vuity, an eye drop for the treatment of presbyopia, is now available, according to a press release from AbbVie. ...

Add Yahoo as a preferred source to see more of our stories on Google. When people get into their 40s and beyond, their close-up vision starts to worsen. For many people, cranking up the font size on a ...

EDOF technology, previously used in intraocular lenses, is now available in contact lenses, offering significant improvements ...

A new once-a-day eye drop designed to improve blurry vision in adults is now commercially available in the United States. The product, known as VIZZ 1.44%, offers a nonsurgical option for people ...

Deseyne ® (vifilcon C) Daily Disposable Soft (Hydrophilic) Contact Lens for Presbyopia with Extended Depth of Focus (EDOF) Delivers Continuous Vision at All Distances—Redefining Presbyopia Correction ...

The US Food and Drug Administration for the first time has approved an eye drop to treat presbyopia, also known as age-related blurry near vision, in adults. Pilocarpine HCl ophthalmic solution 1.25% ...

The FDA approved aceclidine 1.44% ophthalmic solution (Vizz) for adults with presbyopia, or age-related blurred near vision, maker Lenz Therapeutics announced on Thursday. It marks the first ...

BOSTON — The investigational Raindrop transparent hydrogel corneal inlay (ReVision Optics) is consistently effective in the correction of presbyopia, relatively easy to implant, and has high patient ...

GENEVA--(BUSINESS WIRE)--Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced the global launch of TOTAL30 ® Multifocal, the first and only ...